SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis

Yang,Mengyuan; Xie,Xiaohui; Ding,Yiling

doi:10.3892/or.2016.4545

SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis

Authors:
- Mengyuan Yang
- Xiaohui Xie
- Yiling Ding
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, P.R. China
Published online on: January 5, 2016 https://doi.org/10.3892/or.2016.4545
Pages: 1796-1806

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Spalt-like transcription factor 4 (SALL4) is a transcription factor which is able to regulate development and embryonic stem cell pluripotency, and it is also involved in some tumor progression. However, the role of SALL4 in serous ovarian carcinoma (SOC) is still controversial. In this study, we determined the SALL4 expression in ovarian carcinoma (OC) cell lines and SOC tissues, and explored the clinical value of SALL4 in SOC. The SALL4 mRNA and protein expression in OC cell lines were examined by real-time PCR and western blotting. The SALL4 protein expression of 91 SOC tissue samples were examined by immunohistochemistry, and the correlation with clinicopathologic features as well as the survivals of SOC patients were analyzed. The invasion potential of OC cells were determined by cytoskeleton immunofluorescence, wound-healing, Transwell and colony formation assays. Our study found SALL4 mRNA and protein were highly expressed in OC cell lines, especially in HO-8910PM. SALL4 protein was highly expressed in SOC tissues, and positively associated with advanced FIGO stage, high histological grade, lymph node involvement, distant metastasis, recurrence and death of SOC (all P<0.05). Survival analysis showed that high expression of SALL4 indicated poorer overall and progression-free survival (P<0.05). Univariate and multivariate analysis showed that SALL4 is an independent marker for prognosis prediction (P<0.05). SALL4 ectopic expression significantly increased the migration, invasion and proliferation capacity of OC cells. In contrast, inhibition of SALL4 markedly decreased these capacities in vitro. In addition, SALL4-interference changed critical signaling involved in cancer progression. In conclusion, SALL4 was highly expressed and correlated with poor prognosis in SOC patients, promoting invasion and metastasis of OC cells. SALL4 could be a novel molecular target and prognostic marker for SOC.

View Figures

View References

1	Jayson GC, Kohn EC, Kitchener HC and Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014. View Article : Google Scholar : PubMed/NCBI
2	Cannistra SA: Cancer of the ovary. N Engl J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
3	Xiong J: SALL4: Engine of cell stemness. Curr Gene Ther. 14:400–411. 2014. View Article : Google Scholar : PubMed/NCBI
4	Tan MH, Au KF, Leong DE, Foygel K, Wong WH and Yao MW: An Oct4-Sall4-Nanog network controls developmental progression in the pre-implantation mouse embryo. Mol Syst Biol. 9:6322013. View Article : Google Scholar : PubMed/NCBI
5	Rao S, Zhen S, Roumiantsev S, McDonald LT, Yuan GC and Orkin SH: Differential roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol Cell Biol. 30:5364–5380. 2010. View Article : Google Scholar : PubMed/NCBI
6	Uez N, Lickert H, Kohlhase J, de Angelis MH, Kühn R, Wurst W and Floss T: Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. Genesis. 46:463–477. 2008. View Article : Google Scholar : PubMed/NCBI
7	Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, et al: Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 8:1114–1123. 2006. View Article : Google Scholar : PubMed/NCBI
8	Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS and Chai L: SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood. 108:2726–2735. 2006. View Article : Google Scholar : PubMed/NCBI
9	Li A, Yang Y, Gao C, Lu J, Jeong HW, Liu BH, Tang P, Yao X, Neuberg D, Huang G, et al: A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. J Clin Invest. 123:4195–4207. 2013. View Article : Google Scholar : PubMed/NCBI
10	Ardalan Khales S, Abbaszadegan MR, Abdollahi A, Raeisossadati R, Tousi MF and Forghanifard MM: SALL4 as a new biomarker for early colorectal cancers. J Cancer Res Clin Oncol. 141:229–235. 2015. View Article : Google Scholar
11	Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M, Zhang X, Yang T, Cai J, Yan Y, et al: SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene. 33:5491–5500. 2014. View Article : Google Scholar
12	Masuda S, Suzuki K and Izpisua Belmonte JC: Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 369:11712013.PubMed/NCBI
13	Kobayashi D, Kuribayshi K, Tanaka M and Watanabe N: SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. Int J Oncol. 38:933–939. 2011.PubMed/NCBI
14	Jelovac D and Armstrong DK: Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
15	Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, Zhao Y, Reynolds S, Cheng H, Rupaimoole R, et al: Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 23:186–199. 2013. View Article : Google Scholar : PubMed/NCBI
16	Bast RC Jr, Hennessy B and Mills GB: The biology of ovarian cancer: New opportunities for translation. Nat Rev Cancer. 9:415–428. 2009. View Article : Google Scholar : PubMed/NCBI
17	Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ; American Cancer Society: Cancer statistics, 2004. CA Cancer J Clin. 54:8–29. 2004. View Article : Google Scholar : PubMed/NCBI
18	Kohlhase J, Schubert L, Liebers M, Rauch A, Becker K, Mohammed SN, Newbury-Ecob R and Reardon W: Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J Med Genet. 40:473–478. 2003. View Article : Google Scholar : PubMed/NCBI
19	Al-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, McIntosh N, Nakano M, Martonyi EJ, Raymond WR, Okumura S, et al: Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet. 71:1195–1199. 2002. View Article : Google Scholar : PubMed/NCBI
20	Zhang X, Yuan X, Zhu W, Qian H and Xu W: SALL4: An emerging cancer biomarker and target. Cancer Lett. 357:55–62. 2015. View Article : Google Scholar
21	Kobayashi D, Kuribayashi K, Tanaka M and Watanabe N: Overexpression of SALL4 in lung cancer and its importance in cell proliferation. Oncol Rep. 26:965–970. 2011.PubMed/NCBI
22	Hobbs RM, Fagoonee S, Papa A, Webster K, Altruda F, Nishinakamura R, Chai L and Pandolfi PP: Functional antagonism between Sall4 and Plzf defines germline progenitors. Cell Stem Cell. 10:284–298. 2012. View Article : Google Scholar : PubMed/NCBI
23	Trinh DT, Shibata K, Hirosawa T, Umezu T, Mizuno M, Kajiyama H and Kikkawa F: Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary. J Obstet Gynaecol Res. 38:841–848. 2012. View Article : Google Scholar : PubMed/NCBI
24	Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J and Lee YS: SALL4 expression in germ cell and non-germ cell tumors: A systematic immunohistochemical study of 3215 cases. Am J Surg Pathol. 38:410–420. 2014. View Article : Google Scholar : PubMed/NCBI
25	Böhm J, Sustmann C, Wilhelm C and Kohlhase J: SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway. Biochem Biophys Res Commun. 348:898–907. 2006. View Article : Google Scholar : PubMed/NCBI
26	Cao L, Shao M, Schilder J, Guise T, Mohammad KS and Matei D: Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 31:2521–2534. 2012. View Article : Google Scholar
27	Li A, Jiao Y, Yong KJ, Wang F, Gao C, Yan B, Srivastava S, Lim GS, Tang P, Yang H, et al: SALL4 is a new target in endometrial cancer. Oncogene. 34:63–72. 2015. View Article : Google Scholar
28	Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A and Postigo A: EMT-activating transcription factors in cancer: Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456. 2012. View Article : Google Scholar : PubMed/NCBI
29	Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
30	Lim J and Thiery JP: Epithelial-mesenchymal transitions: Insights from development. Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
31	Yi BR, Kim TH, Kim YS and Choi KC: Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers. Int J Oncol. 46:272–280. 2015.
32	Chao TK, Yo YT, Liao YP, Wang YC, Su PH, Huang TS and Lai HC: LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer. Gynecol Oncol. 128:475–482. 2013. View Article : Google Scholar
33	Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM and Thiery JP: The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 46:1–8. 2015. View Article : Google Scholar